User profiles for "author:Jeffrey R Gingrich"

Jeffrey R. Gingrich

Duke University
Verified email at duke.edu
Cited by 9262

Src in synaptic transmission and plasticity

LV Kalia, JR Gingrich, MW Salter - Oncogene, 2004 - nature.com
In the central nervous system (CNS), Src and other Src family kinases are widely expressed
and are abundant in neurons. Src has been implicated in proliferation and differentiation …

[HTML][HTML] Radical prostatectomy versus observation for localized prostate cancer

TJ Wilt, MK Brawer, KM Jones, MJ Barry… - … England Journal of …, 2012 - Mass Medical Soc
Background The effectiveness of surgery versus observation for men with localized prostate
cancer detected by means of prostate-specific antigen (PSA) testing is not known. Methods …

Metastatic prostate cancer in a transgenic mouse

JR Gingrich, RJ Barrios, RA Morton, BF Boyce… - Cancer research, 1996 - AACR
We have previously reported the development of a transgenic mouse model for prostate
cancer derived from PB-Tag transgenic line 8247, henceforth designated the TRAMP …

Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model

BA Foster, JR Gingrich, ED Kwon, C Madias… - Cancer research, 1997 - AACR
To develop a syngeneic transplantable system to study immunotherapeutic approaches for
the treatment of prostate cancer, three cell lines were established from a heterogeneous 32 …

Androgen-independent prostate cancer progression in the TRAMP model

JR Gingrich, RJ Barrios, MW Kattan, HS Nahm… - Cancer research, 1997 - AACR
We previously established the autochthonous transgenic adenocarcinoma mouse prostate
(TRAMP) model to facilitate characterization of molecular mechanisms involved in the …

Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex

XJ Liu, JR Gingrich, M Vargas-Caballero, YN Dong… - Nature medicine, 2008 - nature.com
Chronic pain hypersensitivity depends on N-methyl-d-aspartate receptors (NMDARs).
However, clinical use of NMDAR blockers is limited by side effects resulting from …

Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer

R Pili, M Häggman, WM Stadler, JR Gingrich… - Journal of Clinical …, 2011 - ascopubs.org
Purpose The activity of the novel antitumor agent tasquinimod (TASQ) with S100A9 as a
molecular target was investigated in men with metastatic castration-resistant prostate cancer …

Inducible gene expression in the nervous system of transgenic mice

JR Gingrich, J Roder - Annual review of neuroscience, 1998 - annualreviews.org
▪ Abstract Gene function during mammalian development is often studied by making
irreversible changes to the genome. This approach has a major drawback in that the …

The Prostate cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program# 407 (PIVOT): design and baseline results of a randomized …

TJ Wilt, MK Brawer, MJ Barry, KM Jones, Y Kwon… - Contemporary clinical …, 2009 - Elsevier
BACKGROUND: Prostate cancer is the most common noncutaneous malignancy and the
second leading cause of cancer death in men. Ninety percent of men with prostate cancer …

Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2

JR Gingrich, KA Pelkey, SR Fam… - Proceedings of the …, 2004 - National Acad Sciences
Src is the prototypic protein tyrosine kinase and is critical for controlling diverse cellular
functions. Regions in Src define structural and functional domains conserved in many cell …